4.35 USD
▼0.00-2.25%
盘后 4.12 -7.42%
2026-08-03
市值
$8.74M
市盈率
—
EPS
-10.43
股息率
—
52 周区间
3.25 – 41.80
成交量
9.04K
Beta
1.66
目标价
21.40
52W 低 3.2552W 高 41.80
价格走势
公司简介
Quoin Pharmaceuticals, Ltd., a late-stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States. The company’s lead product is QRX003, a topical lotion, which is in phase 2 to treat netherton syndrome (NS); phase 1 in to treat peeling skin syndrome; and in pre-clinical stage to treat SAM syndrome and ichthyosis. It also develops QRX008 for the treatment of scleroderma, which is in pre-clinical stage; and QRX009, to treat microcystic lymphatic ...